-
1دورية أكاديمية
المؤلفون: Liu, YimengAff1, Aff2, Yu, Ze, Ye, Xuxiao, Zhang, Jinyuan, Hao, Xin, Gao, Fei, Yu, JingAff1, Aff2, IDs11096024017297_cor7, Zhou, ChunhuaAff1, Aff2
المصدر: International Journal of Clinical Pharmacy. 46(4):926-936
-
2دورية أكاديمية
المصدر: Nature and Science of Sleep, Vol Volume 15, Pp 767-778 (2023)
مصطلحات موضوعية: sodium oxybate, low-sodium oxybate, calcium, magnesium, potassium, and sodium oxybates, prescribing patterns, personalized dosing, Psychiatry, RC435-571, Neurophysiology and neuropsychology, QP351-495
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Bárbara Costa, Nuno Vale
المصدر: Journal of Clinical Medicine, Vol 13, Iss 15, p 4398 (2024)
مصطلحات موضوعية: psychotropic therapy, pregnant women, maternal mental health, pharmacokinetics, personalized dosing, therapeutic monitoring, Medicine
وصف الملف: electronic resource
-
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
7دورية أكاديمية
المؤلفون: Manuel Mena, Julio-Cesar Garcia, Rosa-Helena Bustos
المصدر: Antibiotics, Vol 12, Iss 2, p 301 (2023)
مصطلحات موضوعية: vancomycin, Bayesian prediction, population pharmacokinetics, personalized dosing, individualized therapy, critical ill patients, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
8دورية أكاديمية
المؤلفون: Lin Huo, Yuepeng Tang
المصدر: Applied Sciences, Vol 13, Iss 1, p 325 (2022)
مصطلحات موضوعية: chemotherapy, multi-objective reinforcement learning, multi-criteria decision making, personalized dosing, Technology, Engineering (General). Civil engineering (General), TA1-2040, Biology (General), QH301-705.5, Physics, QC1-999, Chemistry, QD1-999
وصف الملف: electronic resource
-
9دورية أكاديمية
المؤلفون: Xianfu Li, En Liang, Xiaoxuan Hong, Xiaolu Han, Conghui Li, Yuxi Wang, Zengming Wang, Aiping Zheng
المصدر: Pharmaceutics, Vol 14, Iss 1, p 20 (2021)
مصطلحات موضوعية: Binder jet 3D printing, physiological pharmacokinetic modeling, levetiracetam, bioequivalence, personalized dosing, Pharmacy and materia medica, RS1-441
وصف الملف: electronic resource
-
10
المؤلفون: Meertens, Marinda, Muntinghe-Wagenaar, M Benthe, Sikkema, Barend J, Lopez-Yurda, Marta, Retèl, Valesca P, Paats, Marthe S, Ter Heine, Rob, Schuuring, Ed, Timens, Wim, Touw, Daan J, van Boven, Job F M, de Langen, Adrianus J, Hashemi, Sayed M S, Hendriks, Lizza E L, Croes, Sander, van den Heuvel, Michel M, Dingemans, Anne-Marie C, Mathijssen, Ron H J, Smit, Egbert F, Huitema, Alwin D R, Steeghs, Neeltje, van der Wekken, Anthonie J
المساهمون: Pulmonary medicine, AII - Cancer immunology, CCA - Cancer Treatment and quality of life, CCA - Cancer biology and immunology, Targeted Gynaecologic Oncology (TARGON), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Groningen Research Institute for Asthma and COPD (GRIAC), Pharmaceutical Analysis, Critical care, Anesthesiology, Peri-operative and Emergency medicine (CAPE), Medicinal Chemistry and Bioanalysis (MCB), Biopharmaceuticals, Discovery, Design and Delivery (BDDD), Value, Affordability and Sustainability (VALUE), Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Medical Oncology, Pulmonary Medicine
المصدر: Frontiers in Oncology, 13:1136221. Frontiers Media S.A.
Frontiers in Oncology, 13
Frontiers in Oncology, 13:1136221. Frontiers Media SA
Meertens, M, Muntinghe-Wagenaar, M B, Sikkema, B J, Lopez-Yurda, M, Retèl, V P, Paats, M S, ter Heine, R, Schuuring, E, Timens, W, Touw, D J, van Boven, J F M, de Langen, A J, Hashemi, S M S, Hendriks, L E L, Croes, S, van den Heuvel, M M, Dingemans, A-M C, Mathijssen, R H J, Smit, E F, Huitema, A D R, Steeghs, N & van der Wekken, A J 2023, ' Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients : Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC) ', Frontiers in Oncology, vol. 13, 1136221 . https://doi.org/10.3389/fonc.2023.1136221مصطلحات موضوعية: Cancer Research, therapeutic drug monitoring, personalized dosing, anaplastic lymphoma kinase, Rare cancers Radboud Institute for Molecular Life Sciences [Radboudumc 9], OPEN-LABEL, protein kinase inhibitors, All institutes and research themes of the Radboud University Medical Center, lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4], Oncology, SDG 3 - Good Health and Well-being, randomized controlled trial, SURVIVAL, CRIZOTINIB, pharmacokinetics, cost-effectiveness, non-small cell lung cancer
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e576f28de6b41eb91ecf66ac5d15a00b
https://hdl.handle.net/11370/1269da41-d5cc-4761-8e6b-8a60aa2ecedb